Letter to the Editor: regarding "Prospective Analysis of Association Between Use of Statins or Other Lipid-Lowering Agents and Colorectal Cancer Risk"

被引：0
|
作者：
Lai, Shih-Wei [1 ,2 ]
Liao, Kuan-Fu [3 ,4 ]
机构：
[1] China Med Univ, Sch Med, Taichung, Taiwan
[2] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan
[3] China Med Univ, Grad Inst Integrated Med, Dept Internal Med, Taichung Tzu Chi Gen Hosp, Taichung, Taiwan
[4] Cent Taiwan Univ Sci & Technol, Dept Hlth Care Adm, Taichung, Taiwan
来源：
ANNALS OF EPIDEMIOLOGY | 2013年 / 23卷 / 01期
关键词：
D O I：
10.1016/j.annepidem.2012.10.008
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [31] Prospective analysis of association between statins and pancreatic cancer risk in the Women’s Health Initiative
    Michael S. Simon
    Pinkal Desai
    Robert Wallace
    Chunyuan Wu
    Barbara V. Howard
    Lisa W. Martin
    Nicolas Schlecht
    Simin Liu
    Allison Jay
    Erin S. LeBlanc
    Thomas Rohan
    JoAnn Manson
    Cancer Causes & Control, 2016, 27 : 415 - 423
  • [32] Prospective analysis of association between statins and pancreatic cancer risk in the Women's Health Initiative
    Simon, Michael S.
    Desai, Pinkal
    Wallace, Robert
    Wu, Chunyuan
    Howard, Barbara V.
    Martin, Lisa W.
    Schlecht, Nicolas
    Liu, Simin
    Jay, Allison
    LeBlanc, Erin S.
    Rohan, Thomas
    Manson, JoAnn
    CANCER CAUSES & CONTROL, 2016, 27 (03) : 415 - 423
  • [33] Benefit-Risk Assessment of Statins (Lipid Lowering Agents): A Multi-Criteria Decision Analysis
    Wanishayakorn, Tanatape
    Ngorsuraches, Surachat
    JOURNAL OF MULTI-CRITERIA DECISION ANALYSIS, 2016, 23 (1-2) : 28 - 39
  • [34] LETTER TO THE EDITOR ASSOCIATION BETWEEN STATIN USE AND INCIDENCE OF BREAST CANCER
    Safari, A.
    Salehiniya, H.
    Bakeshei, K. Allah
    Mohammadian-Hafshejani, A.
    WORLD CANCER RESEARCH JOURNAL, 2018, 5 (02)
  • [35] Association between lipid-lowering agents and severe hyponatremia: a population-based case-control study
    Skov, Jakob
    Falhammar, Henrik
    Calissendorff, Jan
    Lindh, Jonatan D.
    Mannheimer, Buster
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (05) : 747 - 755
  • [36] GENETIC ASSOCIATION OF MODIFIABLE RISK FACTORS AND ANTI-HYPERTENSION, LIPID-LOWERING AND ANTIDIABETIC AGENTS WITH LACUNAR STROKE: A MENDELIAN RANDOMIZATION ANALYSIS
    Zhang, L.
    Huang, T.
    Fan, D.
    INTERNATIONAL JOURNAL OF STROKE, 2022, 17 (3_SUPPL) : 278 - 278
  • [37] Lipid-Lowering Therapy and Intracerebral Hemorrhage Risk: Comparative Meta-Analysis of Statins and PCSK9 Inhibitors
    Cuesta, Sanz Borja E.
    Saver, Jeffrey L.
    STROKE, 2021, 52
  • [38] Lipid-Lowering Therapy and Hemorrhagic Stroke Risk Comparative Meta-Analysis of Statins and PCSK9 Inhibitors
    Sanz-Cuesta, Borja E.
    Saver, Jeffrey L.
    STROKE, 2021, 52 (10) : 3142 - 3150
  • [39] Lipid-lowering drug use, duration of use, and age at first use is associated with a lower risk of colorectal cancer mortality in men and women in the Atherosclerosis Risk in Communities (ARIC) Study
    Marrone, Michael T.
    Barber, John R.
    Mondul, Alison M.
    Prizment, Anna E.
    Couper, David
    Joshu, Corinne E.
    Platz, Elizabeth A.
    CANCER RESEARCH, 2020, 80 (16)
  • [40] The association between TyG index and cardiovascular mortality is modified by antidiabetic or lipid-lowering agent: a prospective cohort study
    Changchang Fang
    Nanqin Peng
    Jiang Cheng
    Xiyu Zhang
    Wenli Gu
    Zicheng Zhu
    Xiaoping Yin
    Zhiwei Yan
    Jing Zhang
    Peng Yu
    Xiao Liu
    Cardiovascular Diabetology, 24 (1)
12345